Ephrin‐B2 overexpression predicts for poor prognosis and response to therapy in solid tumors
Ayman Oweida(Université de Sherbrooke), Sana D. Karam(University of Colorado Denver)
Cited by 50
Related Papers
Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution
|Journal of Neuro-Oncology|2017|83
Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization
|Oncotarget|2015|34
FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
|Clinical Cancer Research|2021|34
EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment
|Nature Communications|2022|26
Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
|Journal of Hematology & Oncology|2015|17